GTBL to acquire 13 Sanofi-branded generics for €158 million in cash, expanding anti-infective products and global reach; closing anticipated by Dec 2026, subject to approvals.
AI Assistant
Gujarat Themis Biosyn Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.